The WHO issues interim recommendations for mixing and matching COVID-19 vaccine for second and booster shot, where mRNA-based vaccines can be used as subsequent doses after initial doses of the Oxford-AstraZeneca COVID-19 vaccine and vice-versa, while these vaccines can be used after initial doses of Sinopharm's inactived vaccine.